CD274 and non-small cell lung carcinoma: High expression of PD-L1 is observed in 24–60% of patients with non-small cell lung cancer (NSCLC) [5], and this high expression of PD-L1 has been shown to result in a shorter survival and a poor prognosis for patients [4].